Wick Capital Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Other funds holding BMRN
Wick Capital Partners's BMRN Position: Q3 2026 in Review
Wick Capital Partners reduced its BioMarin Pharmaceuticals (BMRN) stake by 7.9% in Q3 2026, selling an estimated $18.3K and leaving 3,397 shares worth $204K. The position accounts for 0.03% of the portfolio, ranked #327.
Wick Capital Partners first reported a position in BMRN in Q4 2025 and has held it in 4 quarters since. The position peaked at $259K in Q1 2026. 567 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.
- Wick Capital Partners held 3,397 shares of BioMarin Pharmaceuticals worth $204K as of Q3 2026.
- Wick Capital Partners sold 290 BioMarin Pharmaceuticals shares in Q3 2026, an estimated $18.3K.
- BioMarin Pharmaceuticals made up 0.03% of Wick Capital Partners's portfolio in Q3 2026, its #327 holding.
- Wick Capital Partners first reported a position in BioMarin Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
- Wick Capital Partners's BioMarin Pharmaceuticals position peaked at $259K in Q1 2026.
- 567 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.
Based on Wick Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.